In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 
Jasper Brugts
Speaker
Jasper Brugts
Jasper Brugts Jasper Brugts

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

Specialities : Chronic Heart Failure , Acute Heart Failure, Chronic Heart Failure

Heart Failure Cardiologist at the Erasmus MC Thoraxcentre Rotterdam the Netherlands Clinical epidemiologist and clinical trialist

7 presentations from this speaker

Device therapies in Heart failure continuum of care: time to treat!

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : J Bax (Leiden,NL), M Senni (Bergamo,IT), A Chow (London,GB), R Von Bardeleben (Mainz,DE), JJ Brugts (Rotterdam,NL), A Coats (Warwickshire,GB)
  • Sponsored by Abbott

Pulmonary artery pressure monitoring in LVAD patients: The Cardiologist’s Perspective; Take-Home message.

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : JJ Brugts (Rotterdam,NL), J Bax (Leiden,NL), A Coats (Warwickshire,GB)
  • Sponsored by Abbott

Integrating diagnostic data from implanted devices for improved patient management.

Event : EHRA 2019

  • Session : Novel approaches in heart failure management
  • Speaker : JJ Brugts (Rotterdam,NL)
  • Sponsored by Abbott

Optimizing LVAD therapy in advanced heart failure by means of PAP monitoring.

Event : Heart Failure 2019

  • Session : Advances in heart failure management: what if you can do more for more patients?
  • Speaker : JJ Brugts (Rotterdam,NL)
  • Sponsored by Abbott

Real-world heart failure treatment in 10.330 patients with chronic heart failure in the netherlands

Event : Heart Failure 2017

  • Session : Clinical Forum - Sat. 29 April 08:30 - Tues. 02 May at 12:30
  • Speaker : JJ Brugts (Rotterdam,NL)

The treatment benefit of the ACE-inhibitor perindopril on top of beta-blocker therapy in patients with vascular disease

Event : ESC Congress 2016

  • Session : Cardiovascular prevention outcomes I
  • Speaker : JJ Brugts (Rotterdam,NL)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are